Photronics (PLAB) director sells 10,000 shares, keeps 425,850 shares

Rhea-AI Filing Summary

Photronics director Lee Kang Jyh reported selling 10,000 shares of the company’s common stock on January 13, 2026 at an average price of $34.42 per share. The sale was executed in multiple trades at prices ranging from $34.40 to $34.49. After this transaction, Lee still directly beneficially owns 425,850 shares of Photronics common stock.

Insider Trade Summary

Net Seller: 10,000 shares

Net Sell 1 txn

Insider Lee Kang Jyh

Role Director

Sold 10,000 shs ($344K)

Type	Security	Shares	Price	Value
Sale	COMMON STOCK	10,000	$34.42	$344K

Holdings After Transaction: COMMON STOCK — 425,850 shares (Direct)

Footnotes (1)

1. F1. These shares were sold in multiple transactions at prices ranging from $34.40 - $34.49. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 01/15/2026 - 06:58 PM Learn about SEC filing dates

FAQ

What insider transaction did Photronics (PLAB) report in this Form 4?

The Form 4 reports that director Lee Kang Jyh sold 10,000 shares of Photronics common stock on January 13, 2026.

At what price did Lee Kang Jyh sell Photronics (PLAB) shares?

The reported sale was at an average price of $34.42 per share, with individual trades executed between $34.40 and $34.49 per share.

How many Photronics (PLAB) shares does Lee Kang Jyh own after the sale?

Following the reported transaction, Lee Kang Jyh beneficially owns 425,850 shares of Photronics common stock, held directly.

What is the role of the reporting person in Photronics (PLAB)?

The reporting person, Lee Kang Jyh, is identified as a director of Photronics and is not listed as an officer or 10% owner.

Was this a derivative or non-derivative transaction in Photronics (PLAB) stock?

The reported transaction involves non-derivative common stock; there were no derivative securities transactions disclosed in the provided table.

How is the ownership of the sold Photronics (PLAB) shares classified?

The 10,000 shares sold and the remaining 425,850 shares are reported as held under direct ownership by Lee Kang Jyh.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lee Kang Jyh

(Last) (First) (Middle)

15 SECOR ROAD

(Street)

BROOKFIELD CT 06804

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PHOTRONICS INC [ PLAB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
COMMON STOCK	01/13/2026		S		10,000	D	$34.42(1)	425,850	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares were sold in multiple transactions at prices ranging from $34.40 - $34.49. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request.

	/s/Brandon DeSocio, attorney-in-fact for Kang Jyh Lee	01/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.